Icosapent Ethyl Capsules, used to reduce triglyceride levels in adult patients have been launched by Dr. Reddy's Laboratories in the US mar...

Non-Alcoholic Fatty Liver Disease (NAFLD) is a progressive disease of the liver, which starts with fat accumulation in the liver in patient...

The Ahmedabad-based company said the approved product is the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoh...

NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatm...

The company has been granted marketing approval from the Mexican regulatory authority COFEPRIS to commercialise Lipaglyn in Mexico, Zydus s...

The approved product is therapeutically equivalent to the reference listed drug product Trilipix Delayed-Release capsules of Abbvie Inc.

The company has been researching on the drug to treat fatty liver disease or non-alcoholic steatohepatitis apart from diabetic dyslipidemia.

In a December 21 letter to the company, the US FDA has said the “broad statements” made by the company as the “world’s first” is misleading...

Drug firm Zydus Cadila has launched its generic Tenglyn tablets belonging to new class of oral anti-diabetic treatment drugs, Gliptins, in ...

"USFDA has endorsed company's plan to initiate a phase II clinical trial of Saroglitazar in patients with severe hypertriglyceridemia," Zyd...

Ranbaxy received approval from USFDA to manufacture & market Fenofibrate capsules used for lowering high cholesterol & triglyceride levels ...

Amarin Pharma has filed a patent case against Dr Reddy's Labs alleging that the latter is attempting to come out with generic versions of V...

Lupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...

Lupin has launched generic version of Tricor in the US market after getting approval from the US Food and Drug Administration.